跳至主要内容
临床试验/CTRI/2021/08/035999
CTRI/2021/08/035999已完成2 期

Clinical evaluation of raja amirthathi chooranam (internal ) and karappan ennai (external) for the managaement of balakarappan in children

OPD Ayothidass Pandithar hospital National institute of siddha1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年6月9日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Efficacy of the trial drug is measured by using EASI score

研究概览

简要总结

Atopic dermatitis or Eczema is the most common chronic relapsing skin disease seen in infancy and childhood.It is compared with bala karappan in siddha literature. So I have choosen siddha drug formulation Raja amirthathi choornam ( internal) and Karappan ennai (external) to treat the above ailment from authenticated sasthric siddha literature.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
7.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • children with one or more of the following symptoms Itching Erythema Oedema Oozing Crusting and scaling Lichenified plaque.

排除标准

  • Psoriasis Scabies Photo dermatitis Fungal and parasitic skin infections Any other serious illness.

结局指标

主要结局

Efficacy of the trial drug is measured by using EASI score

时间窗: 45 days

and improvement in the clinical conditions will be observed

时间窗: 45 days

次要结局

  • Reduction in the recurrence of the disease and improvement in the quality of life of children(Before and after treatment)

研究者

发起方
OPD Ayothidass Pandithar hospital National institute of siddha
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验